Article Information
History
- February 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jesse Papenburg, MD MSc1,2,3,4,5,
- Jonathon R. Campbell, PhD4,6,
- Chelsea Caya, MScPH3,
- Cynthia Dion3,
- Rachel Corsini, MSc3,
- Matthew P. Cheng, MDCM2,3,6,
- Dick Menzies, MD4,6 and
- Cedric P Yansouni, MD2,3,6,7,#
- 1Division of Pediatric Infectious Diseases, Department of Pediatrics, Montreal Children’s Hospital, Montreal, Quebec, Canada
- 2Division of Microbiology, Department of Clinical Laboratory Medicine, Optilab Montreal - McGill University Health Centre, Montreal, Quebec, Canada
- 3McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada
- 4Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada
- 5Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
- 6Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
- 7J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada
- ↵#Correspondence to: Cédric P Yansouni, MD, J.D. MacLean Centre for Tropical Diseases, Divisions of Infectious Diseases and Medical Microbiology, McGill University Health Centre, 1001 Décarie Blvd., Room EM3.3242, Montreal, Quebec, Canada H4A 3J1, Tel.: 1:514-934-1934 ext. 76173, Email: cedric.yansouni{at}mcgill.ca
Posted February 13, 2022.
Adequacy of serial self-performed SARS-CoV-2 rapid antigen-detection testing for longitudinal mass screening in the workplace
